Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration - 10/10/20
Doi : 10.1016/j.jaad.2020.07.007
Shari R. Lipner, MD, PhD a, ⁎ 
, Yu Wang, BA b
, Yu Wang, BA b a Department of Dermatology, Weill Cornell Medicine, New York, New York
b State University of New York Stonybrook Medical School, Stonybrook, New York
∗Correspondence to: Shari R. Lipner, MD, PhD, 1305 York Ave, New York, NY 100211305 York AveNew YorkNY10021
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 5
P. 1527-1529 - novembre 2020 Retour au numéro
Article précédent
- Sensitivity of Fite-Faraco versus auramine-rhodamine in mycobacterial infection
- Alan N. Snyder, Heather O'Connor, John G. Plante, Latiffa J. Smith, Dirk M. Elston
- Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic
- Raveena Khanna, Christina D. Kwon, Sagar P. Patel, Micah Belzberg, Kyle A. Williams, Ramona Khanna, Emily Boozalis, Shawn G. Kwatra
Bienvenue sur EM-consulte, la référence des professionnels de santé.